Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Raphael Pharmaceutical Inc. (RAPH) had Cash Flow from Financial Activities of $0.24M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.32M |
|
-- |
|
-- |
|
$0.32M |
|
$-0.32M |
|
$0.01M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.32M |
|
$-0.32M |
|
19.63M |
|
19.63M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.03M |
|
$0.00M |
|
$0.00M |
|
$0.03M |
|
$1.08M |
|
-- |
|
-- |
|
$1.08M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
19.63M |
|
| Cash Flow Statement Financials | |
$-0.24M |
|
-- |
|
|
Cash Flow from Financial Activities |
$0.24M |
$0.02M |
|
$0.02M |
|
$0.00M |
|
$0.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
29.39% |
|
29.39% |
|
-1026.67% |
|
29.39% |
|
$-0.05 |
|
$-0.01 |
|
$-0.01 |
|